Lomitapide is a Potent MTP Inhibitor for Hypercholesterolaemia Research
Homozygous familial hypercholesterolaemia (HoFH) is characterised by markedly elevated low-density lipoprotein cholesterol (LDL-C) levels and increased cardiovascular disease burden. Currently available lipid-lowering drugs and apheresis have significantly improved the prognosis…